News Pfizer will have to cut price of AML drug Mylotarg after NIC... NICE blocks access to 65% of patients on cost grounds
Partner Content Partner Content Jayne Hurrell joins OPEN Access Consulting as Director of Gl... Jayne Hurrell joins OPEN Access Consulting as Director
Partner Content Partner Content Matt De Gruchy joins Reynolds Mackenzie as new agency CEO Matt De Gruchy joins Reynolds Mackenzie as new CEO
Partner Content Partner Content Neil Levinson joins ACCRETIO as Strategy Director Neil Levinson joins ACCRETIO as Strategy Director
News Novartis/Amgen's migraine drug hits market at lower than exp... The FDA has approved the first in a new class of migraine drugs, Novartis and Amgen’s Aimovig, and at a lower than expected list price of $6,900.
News Trump drug price plan attacks 'global freeloaders' Donald Trump made great play about his plans to take on big pharma during his presidential campaign – but his plan to cut drug prices has pleased investors and angered those calling for tou
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
